Asia Pacific Medical Devices Reimbursement Market Size & Outlook
Asia Pacific medical devices reimbursement market, 2018-2030 (US$M)
Asia Pacific medical devices reimbursement market highlights
- The Asia Pacific medical devices reimbursement market generated a revenue of USD 116,932.9 million in 2023.
- The market is expected to grow at a CAGR of 9.3% from 2024 to 2030.
- In terms of segment, public was the largest revenue generating payers in 2023.
- Public is the most lucrative payers segment registering the fastest growth during the forecast period.
Asia Pacific data book summary
| Market revenue in 2023 | USD 116,932.9 million |
| Market revenue in 2030 | USD 218,486.1 million |
| Growth rate | 9.3% (CAGR from 2023 to 2030) |
| Largest segment | Public |
| Fastest growing segment | Public |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Public |
| Key market players worldwide | Aviva PLC, CVS Health Corp, BNP Paribas Act. Cat.A, Allianz SE, Humana Inc, The Cigna Group, UnitedHealth Group Inc, Nippon Life Insurance Company of Japan, WellCare Health Plans, Elevance Health |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.5% of the global medical devices reimbursement market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 218,486.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Medical Devices Reimbursement Market Scope
Medical Devices Reimbursement Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific medical devices reimbursement market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical devices reimbursement market will help companies and investors design strategic landscapes.
Public was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific medical devices reimbursement market based on public covering the revenue growth of each sub-segment from 2018 to 2030.
The changing business dynamics and rising cost of medical devices are among the prime factors expected to boost demand for medical devices reimbursement services in countries such as India and China. Established companies located in Western Europe and the U.S. outsource analytical services, site research development, and clinical activities in Asia Pacific.
Establishment of several medical devices reimbursement services across the region has also strengthened medical devices reimbursement market. Moreover, increase in need for cost-effective operations by pharmaceutical companies is also likely to boost medical devices reimbursement market in this region.
The medical devices reimbursement market is expected to witness lucrative growth in countries such as China and India. Government support and availability of skilled practitioners are expected to further contribute to the market growth.
Reasons to subscribe to Asia Pacific medical devices reimbursement market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific medical devices reimbursement market databook
-
Our clientele includes a mix of medical devices reimbursement market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific medical devices reimbursement market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific medical devices reimbursement market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific medical devices reimbursement market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
